Navina co-founders Perera (right) and Ronen Lavi Photo David Garb, courtesy of Grove Ventures
Navina, an Israeli medtech startup that offers a clinical platform for primary care, raised $22 million in a Series B funding round, led by ALIVE Israel HealthTech Fund. The raise doubled the company’s total investment to date to $44 million.
Navina explains that primary care physicians are overwhelmed by catastrophically complex and irregularly structured patient data. These deficiencies often result in missed diagnoses, provider and patient frustration, and economic loss. Navina uses medically-informed AI to restructure chaotic information into an “immediately clear, diagnostically-linked, actionable Patient Portrait. This data presentation gives physicians a radically reinvented view of their patient, resulting in better treatment and reduction of missed diagnoses.”
Navina says that its platform is able to put the “right information in front of physicians at the right time, to give them both a deep understanding of their patients at a glance and actionable insights at the point of care.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
A recent report issued by the Innovation Lab of the American Academy of Family Physicians found that Navina’s platform increases diagnosis accuracy, as well as reduces pre-visit preparation time by a significant 61 percent.
Navina boasts that it has added thousands of new users in the primary care market in 2022 through relationships with sophisticated value-based care and multi-state physician groups across the US. This rapid adoption drove a 10x increase in revenue for Navina, over just the last six months.
“We welcome ALIVE into our family of investors, and are gratified by the continued support of our initial investor group” said Ronen Lavi, co-founder and CEO of Navina. “Our mission, from the beginning, has been to give physicians the time and confidence they need to stay ahead of their patients’ health, and to transform the physician-patient interaction, changing it from reactive to proactive. As Israel’s top HealthTech fund, whose leaders are former directors of the country’s largest hospitals and medical centers and accomplished investors, ALIVE is the ideal partner for this journey.”
Shay Perera, co-founder and CTO, went on to say, “Our investors recognize that AI can enable primary-care doctors to practice medicine the way they desire, while empowering physician groups and health systems to achieve the economics that enable them to meet their responsibilities to the community.”
